Bioequivalence Study of Eltrombopag Olamine Tablets in Healthy Subjects in the Fed State

NCT06768619 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Thrombocytopenia

Interventions

DRUG: Group 1: single-dose of test formulation+single-dose of reference formulation
DRUG: Group 2: single-dose of reference formulation+single-dose of test formulation

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.